MoneyWorks4Me

Wockhardt gets approval to raise funds upto Rs 150 crore

22 Apr 2021 Evaluate

Wockhardt’s the Credit Facilities Committee of the Board of Directors, at its meeting held on April 21, 2021, has approved the raising of funds upto Rs 150 crore through issuance of Rated, Unlisted, Secured Non-Convertible Debentures on private placement basis, in one or more tranches/series to such eligible investors as maybe deemed appropriate.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..